Mobile

An investigational study to assess the safety and effectiveness of a new investgational drug in people with moderately to severely active Ulcerative Colitis

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-005217-24

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To evaluate the efficacy of GS-5745 to induce EBS clinical remission at Week 8 (Cohort 1) • To evaluate the efficacy of GS-5745 to maintain EBS clinical remission at Week 52 (Cohort 2) • To evaluate the safety and tolerability of GS-5745

Critère d'inclusion

  • Ulcerative colitis

Liens